Keros Therapeutics, Inc. - KROS

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 6/9/2026 10:01:39 PM
EDGAR CIK 0001664710

Buy Breakdown

Total $44,700

Sell Breakdown

Total $416,292

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
06/04/2026
10b5-1
06/08/2026
Farzan Nima
Director
Sell
-2,625 @ $10.73
($28,166.25)
 9,767 (-21.18%) Direct
06/04/2026
10b5-1
06/08/2026
Knowles Julius
Director
Sell
-2,625 @ $10.73
($28,166.25)
 10,958 (-19.33%) Direct
06/04/2026
10b5-1
06/05/2026
Seth Alpna
Director
Sell
-2,625 @ $10.72
($28,140.00)
 9,767 (-21.18%) Direct
05/15/2026
10b5-1
05/19/2026
Bienaime Jean Jacques
Director
Buy
1,000 @ $10.58
$10,580.00
 9,450 (11.83%) Direct
04/15/2026
10b5-1
04/17/2026
Bienaime Jean Jacques
Director
Buy
1,000 @ $11.70
$11,700.00
 8,450 (13.42%) Direct
03/09/2026
10b5-1
03/11/2026
Bienaime Jean Jacques
Director
Buy
2,000 @ $11.21
$22,420.00
 7,450 (36.70%) Direct
02/19/2026
02/20/2026
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
CEO Director
Sell
-7,015 @ $16.17
($113,432.55)
 385,708 (-1.79%) Direct
02/18/2026
02/20/2026
Cho Esther
SVP, General Counsel
Officer
Sell
-4,745 @ $16.35
($77,580.75)
 39,755 (-10.66%) Direct
02/18/2026
02/20/2026
Lerner Lorena Raquel
Chief Science Officer
Officer
Sell
-3,873 @ $16.35
($63,323.55)
 31,127 (-11.07%) Direct
02/18/2026
02/20/2026
Regnante Keith
CHIEF FINANCIAL OFFICER
CFO
Sell
-4,739 @ $16.35
($77,482.65)
 39,261 (-10.77%) Direct